164 related articles for article (PubMed ID: 15297969)
1. Expression of candidate tumor markers in ovarian carcinoma and benign ovary: evidence for a link between epithelial phenotype and neoplasia.
Drapkin R; Crum CP; Hecht JL
Hum Pathol; 2004 Aug; 35(8):1014-21. PubMed ID: 15297969
[TBL] [Abstract][Full Text] [Related]
2. The origin of ovarian carcinomas: a unifying hypothesis.
Auersperg N
Int J Gynecol Pathol; 2011 Jan; 30(1):12-21. PubMed ID: 21131839
[TBL] [Abstract][Full Text] [Related]
3. Two types of ovarian cortical inclusion cysts: proposed origin and possible role in ovarian serous carcinogenesis.
Banet N; Kurman RJ
Int J Gynecol Pathol; 2015 Jan; 34(1):3-8. PubMed ID: 25473746
[TBL] [Abstract][Full Text] [Related]
4. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma].
Xiang L; Li J; Wang LJ; Zheng WX; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344
[TBL] [Abstract][Full Text] [Related]
5. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
[TBL] [Abstract][Full Text] [Related]
6. Tubal origin of 'ovarian' low-grade serous carcinoma.
Li J; Abushahin N; Pang S; Xiang L; Chambers SK; Fadare O; Kong B; Zheng W
Mod Pathol; 2011 Nov; 24(11):1488-99. PubMed ID: 21701538
[TBL] [Abstract][Full Text] [Related]
7. Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy.
Park KJ; Patel P; Linkov I; Jotwani A; Kauff N; Pike MC
Histopathology; 2018 Apr; 72(5):766-776. PubMed ID: 29197096
[TBL] [Abstract][Full Text] [Related]
8. The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae.
Auersperg N
Int J Gynecol Pathol; 2013 Sep; 32(5):444-53. PubMed ID: 23896717
[TBL] [Abstract][Full Text] [Related]
9. Expression of p16, p53, CD24, EpCAM and calretinin in serous borderline tumors of the ovary.
Aktaş IY; Buğdayci M; Usubütün A
Turk Patoloji Derg; 2012; 28(3):220-30. PubMed ID: 23011824
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal to epithelial transition in the human ovarian surface epithelium focusing on inclusion cysts.
Okamoto S; Okamoto A; Nikaido T; Saito M; Takao M; Yanaihara N; Takakura S; Ochiai K; Tanaka T
Oncol Rep; 2009 May; 21(5):1209-14. PubMed ID: 19360296
[TBL] [Abstract][Full Text] [Related]
12. Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression.
Houle CD; Ding XY; Foley JF; Afshari CA; Barrett JC; Davis BJ
Gynecol Oncol; 2002 Jul; 86(1):69-78. PubMed ID: 12079303
[TBL] [Abstract][Full Text] [Related]
13. Expression of calretinin in human ovary, testis, and ovarian sex cord-stromal tumors.
Cao QJ; Jones JG; Li M
Int J Gynecol Pathol; 2001 Oct; 20(4):346-52. PubMed ID: 11603218
[TBL] [Abstract][Full Text] [Related]
14. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
Bi SN; Dai SZ; Yao Q; Che YC; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
[TBL] [Abstract][Full Text] [Related]
15. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.
Wang H; Li G; Yin Y; Wang J; Wang H; Wei W; Guo Q; Ma H; Shi Q; Zhou X; Wang J
Int J Clin Exp Pathol; 2014; 7(11):7881-9. PubMed ID: 25550828
[TBL] [Abstract][Full Text] [Related]
16. Microparticles from ovarian carcinomas are shed into ascites and promote cell migration.
Press JZ; Reyes M; Pitteri SJ; Pennil C; Garcia R; Goff BA; Hanash SM; Swisher EM
Int J Gynecol Cancer; 2012 May; 22(4):546-52. PubMed ID: 22315094
[TBL] [Abstract][Full Text] [Related]
17. Application of mesothelin immunostaining in tumor diagnosis.
Ordóñez NG
Am J Surg Pathol; 2003 Nov; 27(11):1418-28. PubMed ID: 14576474
[TBL] [Abstract][Full Text] [Related]
18. Impact and mechanistic role of oral contraceptive pills on the number and epithelial type of ovarian cortical inclusion cysts; a clinicopathology and immunohistochemical study.
DastranjTabrizi A; MostafaGharabaghi P; SheikhzadehHesari F; Sadeghi L; Zamanvandi S; Sarbakhsh P; Ghojazadeh M
Diagn Pathol; 2016 Mar; 11():30. PubMed ID: 27000861
[TBL] [Abstract][Full Text] [Related]
19. Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors.
Gaytan F; Morales C; Barreiro ML; Jeffery P; Chopin LK; Herington AC; Casanueva FF; Aguilar E; Dieguez C; Tena-Sempere M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1798-804. PubMed ID: 15585554
[TBL] [Abstract][Full Text] [Related]
20. Ber-EP4 and anti-calretinin antibodies: a useful combination for differential diagnosis of various histological types of ovarian cancer cells and mesothelial cells.
Okamoto S; Ito K; Sasano H; Moriya T; Niikura H; Terada Y; Sato S; Okamura K; Yaegashi N
Tohoku J Exp Med; 2005 May; 206(1):31-40. PubMed ID: 15802873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
